So many falsehoods so little time. But my favorite is this one
"When it takes 20-30 years to prove your vaccine is efficacious in one indication it isn’t going to be assumed it will work for all indications. "
Stimuvax has been 14 years in development, 12 in the clinic. Easy to recall as of course at the launch of phase I is when I moved here to Seattle. I point this out as you continue to suggest that I was somehow responsible for the design and execution of the assays used some 2 years after left when they started phase II. But don't let facts get in the way of chance at character assasination, it's a big part of the hack game you like to play at various msg boards, and over a period of many years. Sda small existence, but it is what it is.
Back to the point about second and third indications. There are several phase II studies (either recruiting or ongoing/not recruiting) in various indications including breast, MM, colorectal, and prostate cancers. So it will take how many years from now? And you think Merck isn't going to file in breast based on the 400 pt phase II or in MM where the data is near complete. Please do be the one to place that bet against merck. (oh and why not mention the immune response data that has been collected from the phase II studies in multiple indications. might want to read some of the phase II protocols again (oh you didn't read them, and still want to bet on Merck not knowing more than you about immune responses.